BSX
Boston Scientific Corporation
Stock
$42.60−0.63 (−1.46%)Close Oct 2, 2026
- Gross profit, 2025
- $13.9B
- YoY, 2025
- +20.6%
- 5-year CAGR
- +16.5%
- 10-year CAGR
- +10.1%
Gross profit
Gross profit by fiscal year
| Period | Gross profit | YoY |
|---|---|---|
| 2025 | $13.9B | +20.6% |
| 2024 | $11.5B | +16.1% |
| 2023 | $9.9B | +13.4% |
| 2022 | $8.7B | +6.7% |
| 2021 | $8.2B | +26.8% |
| 2020 | $6.4B | −15.4% |
| 2019 | $7.6B | +8.7% |
| 2018 | $7.0B | +8.6% |
| 2017 | $6.5B | +8.3% |
| 2016 | $6.0B | +12.4% |
| 2015 | $5.3B | +2.6% |
| 2014 | $5.2B | +4.0% |
| 2013 | $5.0B | +1.4% |
| 2012 | $4.9B | −1.3% |
| 2011 | $5.0B | −4.7% |
| 2010 | $5.2B | −7.2% |
| 2009 | $5.6B | +0.6% |
| 2008 | $5.6B | −7.2% |
| 2007 | $6.0B | — |